-4%
Hydroxyprogesterone Caproate 250 mg/ml Nuvista Pharma Ltd.Â
Â
Administer intramuscularly at a dose of 500 mg or 250 mg once weekly. Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation. Continue administration once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.
Administration-
- Clean the ampoule top with an alcohol swab before use.
- Draw up 1 ml of drug into a 2 ml syringe.
- After preparing the skin, inject in the upper outer quadrant of the gluteus maximus. The solution is viscous and oily. Slow injection (over one minute or longer) is recommended.
- Applying pressure to the injection site may minimize bruising and swelling.
